Rapid and simultaneous determination of pyrazinamide and its major metabolites in human plasma by high-performance liquid chromatography. 1987

T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D011718 Pyrazinamide A pyrazine that is used therapeutically as an antitubercular agent. Tisamid
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
September 1989, Journal of chromatography,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
May 1991, Journal of chromatography,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
May 1999, Journal of chromatography. B, Biomedical sciences and applications,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
February 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
January 2010, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
December 1980, Journal of chromatography,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
January 1995, Yao xue xue bao = Acta pharmaceutica Sinica,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
January 1989, Therapeutic drug monitoring,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
May 1989, Journal of chromatography,
T Yamamoto, and Y Moriwaki, and S Takahashi, and T Hada, and K Higashino
June 2003, Biomedical chromatography : BMC,
Copied contents to your clipboard!